Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 937 to 948 of 962 entries
Sorted by: Best Match Show Resources per page
[Type 2 diabetes mellitus and depressive symptoms: what is the cause of what? A systematic literature review].

Deutsche medizinische Wochenschrift (1946)

Wagner G, Icks A, Albers B, Abholz HH.
PMID: 22396235
Dtsch Med Wochenschr. 2012 Mar;137(11):523-8. doi: 10.1055/s-0031-1299009. Epub 2012 Mar 06.

BACKGROUND: Diabetes mellitus type 2 and depressive symptoms are statistically associated. The question is if one of the two diseases is causal for the other.METHODS: Systematic review using Medline and searching for prospective controlled population based observational studies and...

Cite
Wagner G, Icks A, Albers B, et al. Diabetes mellitus Typ 2 und Depressivität: Was ist ursächlich für was? Eine systematische Literaturübersicht. [Type 2 diabetes mellitus and depressive symptoms: what is the cause of what? A systematic literature review]. Dtsch Med Wochenschr. 2012;137(11):523-8doi: 10.1055/s-0031-1299009.
Wagner, G., Icks, A., Albers, B., & Abholz, H. H. (2012). Diabetes mellitus Typ 2 und Depressivität: Was ist ursächlich für was? Eine systematische Literaturübersicht. [Type 2 diabetes mellitus and depressive symptoms: what is the cause of what? A systematic literature review]. Deutsche medizinische Wochenschrift (1946), 137(11), 523-8. https://doi.org/10.1055/s-0031-1299009
Wagner, G, et al. "Diabetes mellitus Typ 2 und Depressivität: Was ist ursächlich für was? Eine systematische Literaturübersicht." [Type 2 diabetes mellitus and depressive symptoms: what is the cause of what? A systematic literature review]. Deutsche medizinische Wochenschrift (1946) vol. 137,11 (2012): 523-8. doi: https://doi.org/10.1055/s-0031-1299009
Wagner G, Icks A, Albers B, Abholz HH. Diabetes mellitus Typ 2 und Depressivität: Was ist ursächlich für was? Eine systematische Literaturübersicht. [Type 2 diabetes mellitus and depressive symptoms: what is the cause of what? A systematic literature review]. Dtsch Med Wochenschr. 2012 Mar;137(11):523-8. doi: 10.1055/s-0031-1299009. Epub 2012 Mar 06. German. PMID: 22396235.
Copy Download .nbib Format: NLM
Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Guven DC, Aksun MS, Sahin TK, Aktepe OH, Yildirim HC, Taban H, Ceylan F, Kertmen N, Arik Z, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Erman M.
PMID: 33709186
Support Care Cancer. 2021 Sep;29(9):5417-5423. doi: 10.1007/s00520-021-06139-3. Epub 2021 Mar 11.

PURPOSE: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in cancer patients. However, the association of VTE with immunotherapy remains poorly defined. We therefore evaluated the frequency of VTE in patients receiving immunotherapy and tried to...

Cite
Guven DC, Aksun MS, Sahin TK, et al. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Support Care Cancer. 2021;29(9):5417-5423doi: 10.1007/s00520-021-06139-3.
Guven, D. C., Aksun, M. S., Sahin, T. K., Aktepe, O. H., Yildirim, H. C., Taban, H., Ceylan, F., Kertmen, N., Arik, Z., Dizdar, O., Kilickap, S., Aksoy, S., Yalcin, S., & Erman, M. (2021). Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(9), 5417-5423. https://doi.org/10.1007/s00520-021-06139-3
Guven, Deniz Can, et al. "Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 29,9 (2021): 5417-5423. doi: https://doi.org/10.1007/s00520-021-06139-3
Guven DC, Aksun MS, Sahin TK, Aktepe OH, Yildirim HC, Taban H, Ceylan F, Kertmen N, Arik Z, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Erman M. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Support Care Cancer. 2021 Sep;29(9):5417-5423. doi: 10.1007/s00520-021-06139-3. Epub 2021 Mar 11. PMID: 33709186.
Copy Download .nbib Format: NLM
Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Triozzi JL, Richardson PA, Gregg LP, Navaneethan SD.
PMID: 33599279
Nephrol Dial Transplant. 2021 Jul 23;36(8):1546-1548. doi: 10.1093/ndt/gfab046.

No abstract available.

Cite
Triozzi JL, Richardson PA, Gregg LP, et al. Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease. Nephrol Dial Transplant. 2021;36(8):1546-1548doi: 10.1093/ndt/gfab046.
Triozzi, J. L., Richardson, P. A., Gregg, L. P., & Navaneethan, S. D. (2021). Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 36(8), 1546-1548. https://doi.org/10.1093/ndt/gfab046
Triozzi, Jefferson L, et al. "Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 36,8 (2021): 1546-1548. doi: https://doi.org/10.1093/ndt/gfab046
Triozzi JL, Richardson PA, Gregg LP, Navaneethan SD. Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease. Nephrol Dial Transplant. 2021 Jul 23;36(8):1546-1548. doi: 10.1093/ndt/gfab046. PMID: 33599279; PMCID: PMC8502472.
Copy Download .nbib Format: NLM
On restricted optimal treatment regime estimation for competing risks data.

Biostatistics (Oxford, England)

Zhou J, Zhang J, Lu W, Li X.
PMID: 31373360
Biostatistics. 2021 Apr 10;22(2):217-232. doi: 10.1093/biostatistics/kxz026.

It is well accepted that individualized treatment regimes may improve the clinical outcomes of interest. However, positive treatment effects are often accompanied by certain side effects. Therefore, when choosing the optimal treatment regime for a patient, we need to...

Cite
Zhou J, Zhang J, Lu W, et al. On restricted optimal treatment regime estimation for competing risks data. Biostatistics. 2021;22(2):217-232doi: 10.1093/biostatistics/kxz026.
Zhou, J., Zhang, J., Lu, W., & Li, X. (2021). On restricted optimal treatment regime estimation for competing risks data. Biostatistics (Oxford, England), 22(2), 217-232. https://doi.org/10.1093/biostatistics/kxz026
Zhou, Jie, et al. "On restricted optimal treatment regime estimation for competing risks data." Biostatistics (Oxford, England) vol. 22,2 (2021): 217-232. doi: https://doi.org/10.1093/biostatistics/kxz026
Zhou J, Zhang J, Lu W, Li X. On restricted optimal treatment regime estimation for competing risks data. Biostatistics. 2021 Apr 10;22(2):217-232. doi: 10.1093/biostatistics/kxz026. PMID: 31373360; PMCID: PMC8036005.
Copy Download .nbib Format: NLM
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries.

Journal of the European Academy of Dermatology and Venereology : JEADV

Kandolf-Sekulovic L, Peris K, Stratigos A, Hauschild A, Forsea AM, Lebbe C, Lallas A, Grob JJ, Harwood C, Gogas H, Rutkowski P, Olah J, Kelleners-Smeets NWJ, Paoli J, Dummer R, Moreno-Ramirez D, Bastholt L, Putnik K, Karls R, Hoeller C, Vandersleyen V, Vieira R, Arenberger P, Bylaite-Buckinskiene M, Ocvirk J, Situm M, Weinlich G, Banjin M, Todorovic V, Ymeri A, Zhukavets A, Garbe C.
PMID: 33326646
J Eur Acad Dermatol Venereol. 2021 May;35(5):1119-1132. doi: 10.1111/jdv.17086. Epub 2021 Feb 10.

BACKGROUND AND OBJECTIVES: The incidence of melanoma is increasing. This places significant burden on societies to provide efficient cancer care. The European Cancer Organisation recently published the essential requirements for quality melanoma care. The present study is aimed for...

Cite
Kandolf-Sekulovic L, Peris K, Stratigos A, et al. Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries. J Eur Acad Dermatol Venereol. 2021;35(5):1119-1132doi: 10.1111/jdv.17086.
Kandolf-Sekulovic, L., Peris, K., Stratigos, A., Hauschild, A., Forsea, A. M., Lebbe, C., Lallas, A., Grob, J. J., Harwood, C., Gogas, H., Rutkowski, P., Olah, J., Kelleners-Smeets, N. W. J., Paoli, J., Dummer, R., Moreno-Ramirez, D., Bastholt, L., Putnik, K., Karls, R., Hoeller, C., Vandersleyen, V., Vieira, R., Arenberger, P., Bylaite-Buckinskiene, M., Ocvirk, J., Situm, M., Weinlich, G., Banjin, M., Todorovic, V., Ymeri, A., Zhukavets, A., & Garbe, C. (2021). Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(5), 1119-1132. https://doi.org/10.1111/jdv.17086
Kandolf-Sekulovic, L, et al. "Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries." Journal of the European Academy of Dermatology and Venereology : JEADV vol. 35,5 (2021): 1119-1132. doi: https://doi.org/10.1111/jdv.17086
Kandolf-Sekulovic L, Peris K, Stratigos A, Hauschild A, Forsea AM, Lebbe C, Lallas A, Grob JJ, Harwood C, Gogas H, Rutkowski P, Olah J, Kelleners-Smeets NWJ, Paoli J, Dummer R, Moreno-Ramirez D, Bastholt L, Putnik K, Karls R, Hoeller C, Vandersleyen V, Vieira R, Arenberger P, Bylaite-Buckinskiene M, Ocvirk J, Situm M, Weinlich G, Banjin M, Todorovic V, Ymeri A, Zhukavets A, Garbe C. Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries. J Eur Acad Dermatol Venereol. 2021 May;35(5):1119-1132. doi: 10.1111/jdv.17086. Epub 2021 Feb 10. PMID: 33326646.
Copy Download .nbib Format: NLM
Could the occurrence of neuropsychiatric disorders affect the incidence of stroke and its long-term effects?.

International psychogeriatrics

Filipska K.
PMID: 34423751
Int Psychogeriatr. 2021 Aug;33(8):763-765. doi: 10.1017/S1041610220004184.

No abstract available.

Cite
Filipska K. Could the occurrence of neuropsychiatric disorders affect the incidence of stroke and its long-term effects?. Int Psychogeriatr. 2021;33(8):763-765doi: 10.1017/S1041610220004184.
Filipska, K. (2021). Could the occurrence of neuropsychiatric disorders affect the incidence of stroke and its long-term effects?. International psychogeriatrics, 33(8), 763-765. https://doi.org/10.1017/S1041610220004184
Filipska, Karolina. "Could the occurrence of neuropsychiatric disorders affect the incidence of stroke and its long-term effects?." International psychogeriatrics vol. 33,8 (2021): 763-765. doi: https://doi.org/10.1017/S1041610220004184
Filipska K. Could the occurrence of neuropsychiatric disorders affect the incidence of stroke and its long-term effects?. Int Psychogeriatr. 2021 Aug;33(8):763-765. doi: 10.1017/S1041610220004184. PMID: 34423751.
Copy Download .nbib Format: NLM
Representing Tuberculosis Transmission with Complex Contagion: An Agent-Based Simulation Modeling Approach.

Medical decision making : an international journal of the Society for Medical Decision Making

Zwick ED, Pepperell CS, Alagoz O.
PMID: 33904344
Med Decis Making. 2021 Aug;41(6):641-652. doi: 10.1177/0272989X211007842. Epub 2021 Apr 27.

OBJECTIVE: A recent study reported a tuberculosis (TB) outbreak in which, among newly infected individuals, exposure to additional active infections was associated with a higher probability of developing active disease. Referred to as METHODS: We built an ABM of...

Cite
Zwick ED, Pepperell CS, Alagoz O. Representing Tuberculosis Transmission with Complex Contagion: An Agent-Based Simulation Modeling Approach. Med Decis Making. 2021;41(6):641-652doi: 10.1177/0272989X211007842.
Zwick, E. D., Pepperell, C. S., & Alagoz, O. (2021). Representing Tuberculosis Transmission with Complex Contagion: An Agent-Based Simulation Modeling Approach. Medical decision making : an international journal of the Society for Medical Decision Making, 41(6), 641-652. https://doi.org/10.1177/0272989X211007842
Zwick, Erin D, et al. "Representing Tuberculosis Transmission with Complex Contagion: An Agent-Based Simulation Modeling Approach." Medical decision making : an international journal of the Society for Medical Decision Making vol. 41,6 (2021): 641-652. doi: https://doi.org/10.1177/0272989X211007842
Zwick ED, Pepperell CS, Alagoz O. Representing Tuberculosis Transmission with Complex Contagion: An Agent-Based Simulation Modeling Approach. Med Decis Making. 2021 Aug;41(6):641-652. doi: 10.1177/0272989X211007842. Epub 2021 Apr 27. PMID: 33904344; PMCID: PMC8295181.
Copy Download .nbib Format: NLM
The Incidence and Mortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19 Cases: A Systematic Review and Meta-Analysis.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Parsay S, Vosoughi A, Khabbaz A, Sadigh-Eteghad S.
PMID: 33360509
J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105552. doi: 10.1016/j.jstrokecerebrovasdis.2020.105552. Epub 2020 Dec 17.

OBJECTIVES: Coronavirus disease 2019 (COVID-19) is primarily known as a respiratory illness; however, a wide variety of symptoms and complications of the central nervous system (CNS), such as ischemic cerebrovascular accidents (CVA) have been reported. Hereby, we provide a...

Cite
Parsay S, Vosoughi A, Khabbaz A, et al. The Incidence and Mortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19 Cases: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2020;30(3):105552doi: 10.1016/j.jstrokecerebrovasdis.2020.105552.
Parsay, S., Vosoughi, A., Khabbaz, A., & Sadigh-Eteghad, S. (2021). The Incidence and Mortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19 Cases: A Systematic Review and Meta-Analysis. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 30(3), 105552. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105552
Parsay, Sina, et al. "The Incidence and Mortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19 Cases: A Systematic Review and Meta-Analysis." Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association vol. 30,3 (2021): 105552. doi: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105552
Parsay S, Vosoughi A, Khabbaz A, Sadigh-Eteghad S. The Incidence and Mortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19 Cases: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105552. doi: 10.1016/j.jstrokecerebrovasdis.2020.105552. Epub 2020 Dec 17. PMID: 33360509; PMCID: PMC7746086.
Copy Download .nbib Format: NLM
Incidence and Group Comparisons of Harassment Based on Gender, LGBTQ+ Identity, and Race at an Academic Medical Center.

Journal of women's health (2002)

Vargas EA, Brassel ST, Perumalswami CR, Johnson TRB, Jagsi R, Cortina LM, Settles IH.
PMID: 33216670
J Womens Health (Larchmt). 2021 Jun;30(6):789-798. doi: 10.1089/jwh.2020.8553. Epub 2020 Nov 19.

No abstract available.

Cite
Vargas EA, Brassel ST, Perumalswami CR, et al. Incidence and Group Comparisons of Harassment Based on Gender, LGBTQ+ Identity, and Race at an Academic Medical Center. J Womens Health (Larchmt). 2020;30(6):789-798doi: 10.1089/jwh.2020.8553.
Vargas, E. A., Brassel, S. T., Perumalswami, C. R., Johnson, T. R. B., Jagsi, R., Cortina, L. M., & Settles, I. H. (2021). Incidence and Group Comparisons of Harassment Based on Gender, LGBTQ+ Identity, and Race at an Academic Medical Center. Journal of women's health (2002), 30(6), 789-798. https://doi.org/10.1089/jwh.2020.8553
Vargas, Emily A, et al. "Incidence and Group Comparisons of Harassment Based on Gender, LGBTQ+ Identity, and Race at an Academic Medical Center." Journal of women's health (2002) vol. 30,6 (2021): 789-798. doi: https://doi.org/10.1089/jwh.2020.8553
Vargas EA, Brassel ST, Perumalswami CR, Johnson TRB, Jagsi R, Cortina LM, Settles IH. Incidence and Group Comparisons of Harassment Based on Gender, LGBTQ+ Identity, and Race at an Academic Medical Center. J Womens Health (Larchmt). 2021 Jun;30(6):789-798. doi: 10.1089/jwh.2020.8553. Epub 2020 Nov 19. PMID: 33216670.
Copy Download .nbib Format: NLM
The road to zero nosocomial infections in neonates-a narrative review.

Acta paediatrica (Oslo, Norway : 1992)

Jansen SJ, Lopriore E, van der Beek MT, Veldkamp KE, Steggerda SJ, Bekker V.
PMID: 33955065
Acta Paediatr. 2021 Aug;110(8):2326-2335. doi: 10.1111/apa.15886. Epub 2021 May 06.

AIM: Nosocomial infections (NI) in neonates are associated with prolonged hospitalisation, adverse neurodevelopmental outcome and high mortality. Over the past decade, numerous prevention strategies have resulted in significant reductions in NI rates. In this review, we aim to provide...

Cite
Jansen SJ, Lopriore E, van der Beek MT, et al. The road to zero nosocomial infections in neonates-a narrative review. Acta Paediatr. 2021;110(8):2326-2335doi: 10.1111/apa.15886.
Jansen, S. J., Lopriore, E., van der Beek, M. T., Veldkamp, K. E., Steggerda, S. J., & Bekker, V. (2021). The road to zero nosocomial infections in neonates-a narrative review. Acta paediatrica (Oslo, Norway : 1992), 110(8), 2326-2335. https://doi.org/10.1111/apa.15886
Jansen, Sophie J, et al. "The road to zero nosocomial infections in neonates-a narrative review." Acta paediatrica (Oslo, Norway : 1992) vol. 110,8 (2021): 2326-2335. doi: https://doi.org/10.1111/apa.15886
Jansen SJ, Lopriore E, van der Beek MT, Veldkamp KE, Steggerda SJ, Bekker V. The road to zero nosocomial infections in neonates-a narrative review. Acta Paediatr. 2021 Aug;110(8):2326-2335. doi: 10.1111/apa.15886. Epub 2021 May 06. PMID: 33955065; PMCID: PMC8359829.
Copy Download .nbib Format: NLM
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study.

Pregnancy hypertension

Tan JS, Liu NN, Guo TT, Hu S, Hua L.
PMID: 34428710
Pregnancy Hypertens. 2021 Dec;26:17-23. doi: 10.1016/j.preghy.2021.08.112. Epub 2021 Aug 19.

AIMS: The aim of this study was to apply the Mendelian randomization (MR) design to explore the potential causal association between COVID-19 and the risk of hypertension disorders in pregnancy.METHODS: Our primary genetic instrument comprised 8 single-nucleotide polymorphisms (SNPs)...

Cite
Tan JS, Liu NN, Guo TT, et al. Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study. Pregnancy Hypertens. 2021;26:17-23doi: 10.1016/j.preghy.2021.08.112.
Tan, J. S., Liu, N. N., Guo, T. T., Hu, S., & Hua, L. (2021). Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study. Pregnancy hypertension, 2617-23. https://doi.org/10.1016/j.preghy.2021.08.112
Tan, Jiang-Shan, et al. "Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study." Pregnancy hypertension vol. 26 (2021): 17-23. doi: https://doi.org/10.1016/j.preghy.2021.08.112
Tan JS, Liu NN, Guo TT, Hu S, Hua L. Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study. Pregnancy Hypertens. 2021 Dec;26:17-23. doi: 10.1016/j.preghy.2021.08.112. Epub 2021 Aug 19. PMID: 34428710.
Copy Download .nbib Format: NLM
Lifestyle Effects on the Risk of Transmission of COVID-19 in the United States: Evaluation of Market Segmentation Systems.

International journal of environmental research and public health

Ozdenerol E, Seboly J.
PMID: 33946523
Int J Environ Res Public Health. 2021 Apr 30;18(9). doi: 10.3390/ijerph18094826.

The aim of this study was to associate lifestyle characteristics with COVID-19 infection and mortality rates at the U.S. county level and sequentially map the impact of COVID-19 on different lifestyle segments. We used analysis of variance (ANOVA) statistical...

Cite
Ozdenerol E, Seboly J. Lifestyle Effects on the Risk of Transmission of COVID-19 in the United States: Evaluation of Market Segmentation Systems. Int J Environ Res Public Health. 2021;18(9)doi: 10.3390/ijerph18094826.
Ozdenerol, E., & Seboly, J. (2021). Lifestyle Effects on the Risk of Transmission of COVID-19 in the United States: Evaluation of Market Segmentation Systems. International journal of environmental research and public health, 18(9), . https://doi.org/10.3390/ijerph18094826
Ozdenerol, Esra, and Seboly, Jacob. "Lifestyle Effects on the Risk of Transmission of COVID-19 in the United States: Evaluation of Market Segmentation Systems." International journal of environmental research and public health vol. 18,9 (2021). doi: https://doi.org/10.3390/ijerph18094826
Ozdenerol E, Seboly J. Lifestyle Effects on the Risk of Transmission of COVID-19 in the United States: Evaluation of Market Segmentation Systems. Int J Environ Res Public Health. 2021 Apr 30;18(9). doi: 10.3390/ijerph18094826. PMID: 33946523; PMCID: PMC8125751.
Copy Download .nbib Format: NLM
Showing 937 to 948 of 962 entries